Skip to Main Content

Shareholder Class Action Filed Against Inovalon Holdings, Inc.

View Complaint

Notice is hereby given that a class action lawsuit has been filed on behalf of those who purchased or otherwise acquired Inovalon Holdings, Inc. (“Inovalon”) (NASDAQ: INOV) Class A common stock pursuant or traceable to the Registration Statement and Prospectus (collectively, the “Registration Statement”) issued in connection with Inovalon’s February 12, 2015 initial public stock offering (the “IPO” or “Offering”).

Inovalon investors may receive additional information about the case by clicking the link "Join this Class Action" above.

According to the complaint, Inovalon provides cloud-based data analytics platforms for health insurance plans, pharmaceutical companies, researchers and others in the healthcare industry.  In February 2015, Inovalon completed the IPO, selling more than 25 million shares of common stock at $27 per share and raising more than $684 million in gross proceeds.

The complaint alleges that the Registration Statement was negligently prepared and, as a result, contained untrue statements of material fact and omitted to state material facts both required by governing regulations and necessary to make the statements made not inaccurate statements of material fact. Specifically, the complaint alleges that the Registration Statement failed to disclose the substantial revenues the company derived from sales in the City of New York and the State of New York. This was material because as it also failed to disclose, the State of New York had recently implemented – and New York City was on the cusp of implementing – substantial corporate tax reforms that would take effect on January 1, 2015 (New York City retroactively) that had significantly increased Inovalon’s purportedly “stable” 39% effective tax rate to 43% and thus negatively impacted Inovalon’s then current and future financial results.

According to the complaint, on August 5, 2015, after the markets closed, Inovalon issued a press release announcing its second quarter 2015 financial results for the interim period ended June 30, 2015. The release disclosed the negative impact the New York State and New York City corporate tax reforms had on Inovalon’s fiscal 2015 earnings and lowered the company’s 2015 earnings forecast accordingly.  Following this news, the price of Inovalon shares fell $7.62 per share, or 30%, from a close of $25.40 per share on August 5, 2015 to trade as low as $17.78 per share in intra-day trading on August 6, 2015, on unusually high trading volume. 

At the time of the filing of the complaint, Inovalon shares trade at less than $18 per share, more than one-third lower than the IPO price.

If you are a member of the class described above, you may no later than August 23, 2016 move the Court to serve as lead plaintiff of the class, if you so choose. 

A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation.  In order to be appointed lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class.  Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. Any member of the purported class may move the court to serve as a lead plaintiff through counsel of their choice, or may choose to do nothing and remain an inactive class member.

Kessler Topaz Meltzer & Check, LLP has not filed a complaint in this matter.  If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP toll free at 1-888-299-7706 or 1-610-667-7706, or via e-mail at For more information about Kessler Topaz Meltzer & Check, LLP, please visit our website at

Kessler Topaz Meltzer & Check, LLP
James Maro, Esq. or Adrienne Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087 1-888-299-7706 (toll free) or 1-610-667-7706
Or by e-mail at

Please complete this form and list your purchase and sale transaction(s) for Inovalon Holdings, Inc. (“Inovalon”) (NASDAQ: INOV) Class A common stock pursuant or traceable to the Registration Statement and Prospectus issued in connection with Inovalon’s February 12, 2015 initial public stock offering (the “IPO” or “Offering”):

* Denotes required field
# of Shares
Price per Share
Principal Amount
Amount Paid
Series or CUSIP
# of Contracts
Price per Contract
Exercise Price
Expiration Date
Did you purchase shares of Inovalon Holdings, Inc. prior to the Class Period?
Are you a current or former employee of Inovalon Holdings, Inc.?
The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.
I agree to the KTMC disclaimer
I would like to receive new case alerts by email